Search

everythinglearnresearchcommunity

for

Search:↓

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Spironolactone may help reduce hair loss in androgenic alopecia.

Spironolactone may help reduce hair loss in androgenic alopecia.

Early treatment of PCOS is crucial for better health and quality of life.

Lifestyle changes like diet and exercise improve PCOS symptoms and fertility.

Woodhouse-Sakati syndrome can cause writer's cramp and other varied symptoms, highlighting the importance of genetic testing for diagnosis.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.